Estradiol transdermal gel - ANI Pharmaceuticals/Antares
Alternative Names: Bio-E-Gel®; E2 gel - ANI Pharmaceuticals/Antares; ElestrinLatest Information Update: 27 Apr 2024
At a glance
- Originator Antares Pharma
- Developer Meda
- Class Antineoplastics; Estradiol congeners; Estrenes; Hormonal replacements; Small molecules
- Mechanism of Action Estrogen receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Vasomotor symptoms
Most Recent Events
- 23 Apr 2024 Endo International has been acquired and merged into Endo, Inc.
- 24 May 2022 Antares Pharma has been acquired by Halozyme Therapeutics
- 05 Aug 2016 Meda has been acquired by Mylan